Correlation Between BioAffinity Technologies and SeqLL

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both BioAffinity Technologies and SeqLL at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining BioAffinity Technologies and SeqLL into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between bioAffinity Technologies Warrant and SeqLL Inc, you can compare the effects of market volatilities on BioAffinity Technologies and SeqLL and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in BioAffinity Technologies with a short position of SeqLL. Check out your portfolio center. Please also check ongoing floating volatility patterns of BioAffinity Technologies and SeqLL.

Diversification Opportunities for BioAffinity Technologies and SeqLL

0.2
  Correlation Coefficient

Modest diversification

The 3 months correlation between BioAffinity and SeqLL is 0.2. Overlapping area represents the amount of risk that can be diversified away by holding bioAffinity Technologies Warra and SeqLL Inc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on SeqLL Inc and BioAffinity Technologies is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on bioAffinity Technologies Warrant are associated (or correlated) with SeqLL. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of SeqLL Inc has no effect on the direction of BioAffinity Technologies i.e., BioAffinity Technologies and SeqLL go up and down completely randomly.

Pair Corralation between BioAffinity Technologies and SeqLL

If you would invest  117.00  in bioAffinity Technologies Warrant on September 3, 2024 and sell it today you would lose (45.00) from holding bioAffinity Technologies Warrant or give up 38.46% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy1.64%
ValuesDaily Returns

bioAffinity Technologies Warra  vs.  SeqLL Inc

 Performance 
       Timeline  
BioAffinity Technologies 

Risk-Adjusted Performance

2 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in bioAffinity Technologies Warrant are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of fairly fragile technical and fundamental indicators, BioAffinity Technologies showed solid returns over the last few months and may actually be approaching a breakup point.
SeqLL Inc 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days SeqLL Inc has generated negative risk-adjusted returns adding no value to investors with long positions. Despite quite persistent basic indicators, SeqLL is not utilizing all of its potentials. The current stock price mess, may contribute to short-term losses for the institutional investors.

BioAffinity Technologies and SeqLL Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with BioAffinity Technologies and SeqLL

The main advantage of trading using opposite BioAffinity Technologies and SeqLL positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if BioAffinity Technologies position performs unexpectedly, SeqLL can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in SeqLL will offset losses from the drop in SeqLL's long position.
The idea behind bioAffinity Technologies Warrant and SeqLL Inc pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.

Other Complementary Tools

Bonds Directory
Find actively traded corporate debentures issued by US companies
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Stocks Directory
Find actively traded stocks across global markets
Fundamental Analysis
View fundamental data based on most recent published financial statements
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios